Our cellular assay platforms enable comprehensive evaluation of compound effects on biological systems, providing critical insights into efficacy, toxicity, and mechanism of action. These assays serve as essential tools in our drug discovery pipeline for flavivirus inhibitors and other therapeutic targets.
Optimization of cell-based assays to evaluate compound toxicity, including MTT, LDH release, and live/dead staining protocols.
Learn MoreDevelopment of reporter gene and phosphorylation-based cell assays to study pathway modulation by small molecule compounds.
Explore PathwaysIntegration of automated microscopy and image analysis for cell-based phenotypic screening and subcellular localization studies.
View Imaging Data